The Enterprise Value as of June 2026 (TTM) for Praxis Precision Medicines, Inc. (PRAX) is 5.10B

According to Praxis Precision Medicines, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 5.10B. This represents a change of 21.39% compared to the average of 4.20B of the last 4 quarters.

Praxis Precision Medicines, Inc. (PRAX) Historical Enterprise Value (quarterly & annually)

How has PRAX Enterprise Value performed in the past?

The mean historical Enterprise Value of Praxis Precision Medicines, Inc. over the last ten years is 1.06B. The current 5.10B Enterprise Value has changed 48.05% with respect to the historical average. Over the past ten years (40 quarters), PRAX's Enterprise Value was at its highest in in the March 2026 quarter at 8.77B. The Enterprise Value was at its lowest in in the June 2023 quarter at -41088177.75.

Praxis Precision Medicines, Inc. (PRAX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Praxis Precision Medicines, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Praxis Precision Medicines, Inc. (PRAX) Average Enterprise Value

How has PRAX Enterprise Value performed in the past?

The current Enterprise Value of Praxis Precision Medicines, Inc. (PRAX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Praxis Precision Medicines, Inc. (PRAX) Enterprise Value vs. Peers

How is PRAX’s Enterprise Value compared to its peers?

Praxis Precision Medicines, Inc.’s Enterprise Value is greater than Crinetics Pharmaceuticals, Inc. (3.57B), greater than Soleno Therapeutics, Inc. (2.63B), greater than Viking Therapeutics, Inc. (3.22B), less than Kymera Therapeutics, Inc. (7.03B), greater than ACADIA Pharmaceuticals Inc. (3.38B), less than Ligand Pharmaceuticals Incorporated (5.46B), greater than Xenon Pharmaceuticals Inc. (3.57B), greater than Akero Therapeutics, Inc. (4.32B), less than Centessa Pharmaceuticals plc (6.09B), less than Immunovant, Inc. (6.00B),

Build a custom stock screener for Praxis Precision Medicines, Inc. (PRAX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Praxis Precision Medicines, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Praxis Precision Medicines, Inc. (PRAX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Praxis Precision Medicines, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.